Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07408089 |
| Title | Study of the Kinesin Oral Molecular Degrader BBI-940 in Subjects With Advanced or Metastatic Breast Cancer (KOMODO-1) |
| Acronym | KOMODO-1 |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | Yes |
| Sponsors | Boundless Bio, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| The START Center for Cancer Research | Los Angeles | California | 90025 | United States | Details | |
| The START Center for Cancer Research | Lake Success | New York | 11042 | United States | Details | |
| NEXT Oncology | Austin | Texas | 78758 | United States | Details | |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75390 | United States | Details | |
| NEXT Oncology | Houston | Texas | 77054 | United States | Details | |
| NEXT Oncology | San Antonio | Texas | 78229 | United States | Details | |
| The START Center for Cancer Care | San Antonio | Texas | 78229 | United States | Details | |
| NEXT Oncology | Fairfax | Virginia | 22031 | United States | Details |